Aarti Drugs' Baddi facility in Himachal Pradesh gets 3 US FDA Form 483 observations
Aarti Drugs said its subsidiary Pinnacle Life Science received three Form 483 observations from the US FDA after an inspection of its Baddi formulations facility between November 2 and 6. None of the observations was…
